EMEA-000178-PIP01-07-M04
Key facts
| Invented name |
Pumarix
|
| Active substance |
Purified antigen fractions of inactivated split virion Influenza A/Indonesia/05/2005(H5N1) like strain used (PR8-IBCDC-RG2)
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/0088/2015
|
| PIP number |
EMEA-000178-PIP01-07-M04
|
| Pharmaceutical form(s) |
Emulsion and suspension for emulsion for injection
|
| Condition(s) / indication(s) |
Prevention of influenza infection
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
GlaxoSmithKline Biologicals S.A. (Belgium)
Tel. +1 438 899 8201 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|